Related Experiment Video
Updated: Jun 19, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
THE EFFECT OF A GROWTH-RETARDING FACTOR FROM NORMAL TISSUES ON SPONTANEOUS CANCER OF MICE
1Laboratories of The Rockefeller Institute for Medical Research.
Abstract:
Extracts of desiccated homologous embryo skin and placenta decrease markedly the rate of postoperative local recurrence after the surgical removal of spontaneous cancer of mice. Autografts after a short period of contact with these extracts either failed to grow, or, in the majority of instances, their subsequent growth was definitely retarded. Intraperitoneal injection of the extracts was followed by cessation of growth of established tumors in more than two-thirds of the animals treated, and among these many of the tumors regressed and over 20 per cent were completely absorbed. Tumor mice treated with either extract rarely developed new malignant foci, though this happened frequently in untreated mice.
Insights
Desiccated embryo skin and placenta extracts significantly reduced cancer recurrence in mice after surgery. These extracts also inhibited tumor growth and prevented new tumor formation in treated animals.
Area of Science:
- Oncology
- Developmental Biology
Background:
- Spontaneous cancers in mice present a challenge for local recurrence post-surgical removal.
- Investigating biological extracts for anti-cancer properties is crucial for therapeutic development.
Purpose of the Study:
- To evaluate the efficacy of desiccated homologous embryo skin and placenta extracts in preventing local recurrence and inhibiting tumor growth in mice with spontaneous cancer.
- To assess the impact of these extracts on tumor regression and the development of new malignant foci.
Main Methods:
- Surgical removal of spontaneous tumors in mice.
- Application of desiccated homologous embryo skin and placenta extracts to surgical sites.
- Assessment of autograft growth after contact with extracts.
- Intraperitoneal administration of extracts to tumor-bearing mice.
- Monitoring tumor growth, regression, absorption, and development of new foci.
Main Results:
- Marked decrease in postoperative local recurrence rates after surgical removal of tumors.
- Autografts showed failed growth or significantly retarded subsequent growth after contact with extracts.
- Cessation of growth in over two-thirds of established tumors following intraperitoneal injection.
- Tumor regression and complete absorption observed in a significant percentage of treated animals (>20% absorbed).
- Reduced incidence of new malignant foci development in treated mice compared to controls.
Conclusions:
- Desiccated homologous embryo skin and placenta extracts demonstrate significant potential in controlling local recurrence and inhibiting tumor progression in a mouse cancer model.
- These findings suggest a therapeutic role for embryo and placenta-derived extracts in cancer management, warranting further investigation.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Replicative Cell Senescence

